1. Home
  2. STE vs PODD Comparison

STE vs PODD Comparison

Compare STE & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo STERIS plc (Ireland)

STE

STERIS plc (Ireland)

HOLD

Current Price

$263.47

Market Cap

25.9B

Sector

Health Care

ML Signal

HOLD

Logo Insulet Corporation

PODD

Insulet Corporation

HOLD

Current Price

$304.01

Market Cap

22.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STE
PODD
Founded
1985
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.9B
22.1B
IPO Year
1992
2007

Fundamental Metrics

Financial Performance
Metric
STE
PODD
Price
$263.47
$304.01
Analyst Decision
Buy
Strong Buy
Analyst Count
9
19
Target Price
$268.25
$359.00
AVG Volume (30 Days)
653.3K
765.6K
Earning Date
11-05-2025
11-06-2025
Dividend Yield
0.96%
N/A
EPS Growth
59.39
N/A
EPS
6.97
3.45
Revenue
$5,702,415,000.00
$2,521,800,000.00
Revenue This Year
$9.24
$32.55
Revenue Next Year
$6.30
$20.39
P/E Ratio
$37.76
$88.24
Revenue Growth
7.08
27.11
52 Week Low
$200.98
$230.05
52 Week High
$268.60
$354.88

Technical Indicators

Market Signals
Indicator
STE
PODD
Relative Strength Index (RSI) 59.06 40.94
Support Level $256.68 $303.20
Resistance Level $268.60 $317.34
Average True Range (ATR) 4.64 13.12
MACD -0.69 -2.82
Stochastic Oscillator 65.59 3.14

Price Performance

Historical Comparison
STE
PODD

About STE STERIS plc (Ireland)

Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Share on Social Networks: